Allopurinol plus standard resuscitation preserves hepatic blood flow and function following hemorrhagic shock

J Trauma. 1994 Dec;37(6):956-61. doi: 10.1097/00005373-199412000-00015.

Abstract

To determine the contribution of ischemia-reperfusion injury (IRI) to the blood flow deficit and hepatocellular dysfunction seen after resuscitation from hemorrhagic shock, the xanthine oxidase inhibitor allopurinol was given to rats as a 50 mg/kg bolus after shock but before resuscitation and continued as a 25 mg/kg/h infusion. Resuscitation with shed blood and lactated Ringer's restored cardiac output and blood pressure in both groups. Control animals demonstrated a reduction in total hepatic and effective hepatic blood flow to 59% and 43% of baseline values, respectively. Allopurinol resulted in a return to baseline values of both variables. Allopurinol treatment resulted in a 350% increase in xanthine, a 630% increase in hypoxanthine, and a 70% reduction in uric acid concentrations. These data suggest that IRI contributes to the organ dysfunction and blood flow deficits seen after resuscitated hemorrhagic shock the effect of which can be attenuated by the addition of the xanthine oxidase inhibitor allopurinol to standard resuscitation.

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Allopurinol / pharmacology*
  • Animals
  • Liver / drug effects*
  • Liver / metabolism
  • Liver / physiopathology
  • Liver Circulation / drug effects*
  • Purines / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Reperfusion Injury / physiopathology
  • Reperfusion Injury / therapy
  • Shock, Hemorrhagic / metabolism
  • Shock, Hemorrhagic / physiopathology
  • Shock, Hemorrhagic / therapy*
  • Xanthine Oxidase / antagonists & inhibitors*

Substances

  • Purines
  • Allopurinol
  • Adenosine Triphosphate
  • Xanthine Oxidase
  • purine